메뉴 건너뛰기




Volumn 2, Issue 1, 2008, Pages 89-94

Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma

Author keywords

Hepatitis B; Hepatocellular carcinoma; Lamivudine; Radiofrequency ablation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINEOPLASTIC AGENT; BILIRUBIN; LAMIVUDINE; VIRUS DNA;

EID: 69749090815     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-007-9020-7     Document Type: Article
Times cited : (43)

References (22)
  • 1
    • 0029147454 scopus 로고
    • Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan
    • Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027-33
    • (1995) Hepatology , vol.22 , pp. 1027-1033
    • Shiratori, Y.1    Shiina, S.2    Imamura, M.3
  • 2
    • 0028961434 scopus 로고
    • Incidence of hepatocellular carcinoma in chronic hepatitis B, C: A prospective study of 251 patients
    • Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B, C: A prospective study of 251 patients. Hepatology 1995;21:650-5
    • (1995) Hepatology , vol.21 , pp. 650-655
    • Takano, S.1    Yokosuka, O.2    Imazeki, F.3    Tagawa, M.4    Omata, M.5
  • 3
    • 0032102924 scopus 로고    scopus 로고
    • Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients
    • Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998;28:930-8
    • (1998) J Hepatol , vol.28 , pp. 930-938
    • Ikeda, K.1    Saitoh, S.2    Suzuki, Y.3
  • 4
    • 20044386501 scopus 로고    scopus 로고
    • Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases
    • Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-9
    • (2005) Cancer , vol.103 , pp. 1201-1209
    • Tateishi, R.1    Shiina, S.2    Teratani, T.3
  • 5
    • 33750129556 scopus 로고
    • Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma
    • Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995;1:73
    • (1995) Cancer J Sci Am , vol.1 , pp. 73
    • Rossi, S.1    Di Stasi, M.2    Buscarini, E.3
  • 6
    • 0032975767 scopus 로고    scopus 로고
    • Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
    • Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61
    • (1999) Radiology , vol.210 , pp. 655-661
    • Livraghi, T.1    Goldberg, S.N.2    Lazzaroni, S.3    Meloni, F.4    Solbiati, L.5    Gazelle, G.S.6
  • 7
    • 0036294013 scopus 로고    scopus 로고
    • Nonsurgical treatment of hepatocellular carcinoma: From percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation
    • Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: From percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62 Suppl 1:64-8
    • (2002) Oncology , vol.62 , Issue.1 SUPPL. , pp. 64-68
    • Shiina, S.1    Teratani, T.2    Obi, S.3    Hamamura, K.4    Koike, Y.5    Omata, M.6
  • 8
    • 0038714350 scopus 로고    scopus 로고
    • Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection
    • Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-40
    • (2003) Radiology , vol.228 , pp. 235-240
    • Lencioni, R.A.1    Allgaier, H.P.2    Cioni, D.3
  • 9
    • 22344454922 scopus 로고    scopus 로고
    • A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
    • Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30
    • (2005) Gastroenterology , vol.129 , pp. 122-130
    • Shiina, S.1    Teratani, T.2    Obi, S.3
  • 10
    • 7044260720 scopus 로고    scopus 로고
    • Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation
    • Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127:S159-66
    • (2004) Gastroenterology , vol.127
    • Omata, M.1    Tateishi, R.2    Yoshida, H.3    Shiina, S.4
  • 11
    • 0032499922 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B infection
    • Omata M. Treatment of chronic hepatitis B infection. N Engl J Med 1998;339:114-5
    • (1998) N Engl J Med , vol.339 , pp. 114-115
    • Omata, M.1
  • 12
    • 17544369393 scopus 로고    scopus 로고
    • Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
    • Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000;31:207-10
    • (2000) Hepatology , vol.31 , pp. 207-210
    • Villeneuve, J.P.1    Condreay, L.D.2    Willems, B.3
  • 13
    • 0034927065 scopus 로고    scopus 로고
    • Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
    • Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort. Hepatology 2001;34:411-6
    • (2001) Hepatology , vol.34 , pp. 411-416
    • Yao, F.Y.1    Terrault, N.A.2    Freise, C.3    Maslow, L.4    Bass, N.M.5
  • 14
    • 19544391413 scopus 로고    scopus 로고
    • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    • Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521-31
    • (2004) N Engl J Med , vol.351 , pp. 1521-1531
    • Liaw, Y.F.1    Sung, J.J.2    Chow, W.C.3
  • 15
    • 0037468421 scopus 로고    scopus 로고
    • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    • Marcellin P, Chang TT, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003;348:808-16
    • (2003) N Engl J Med , vol.348 , pp. 808-816
    • Marcellin, P.1    Chang, T.T.2    Lim, S.G.3
  • 16
    • 0037468406 scopus 로고    scopus 로고
    • Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    • Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 2003;348:800-7
    • (2003) N Engl J Med , vol.348 , pp. 800-807
    • Hadziyannis, S.J.1    Tassopoulos, N.C.2    Heathcote, E.J.3
  • 17
    • 0033520109 scopus 로고    scopus 로고
    • Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan
    • for the IHIT (Inhibition of Hepatocarcinogenesis by Interferon Therapy) Study Group
    • Yoshida H, Shiratori Y, Moriyama M, et al., for the IHIT (Inhibition of Hepatocarcinogenesis by Interferon Therapy) Study Group. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999;131:174-81
    • (1999) Ann Intern Med , vol.131 , pp. 174-181
    • Yoshida, H.1    Shiratori, Y.2    Moriyama, M.3
  • 18
    • 0028876371 scopus 로고
    • Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
    • Nishiguchi S, Kuroki T, Nakatani S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-55
    • (1995) Lancet , vol.346 , pp. 1051-1055
    • Nishiguchi, S.1    Kuroki, T.2    Nakatani, S.3
  • 19
    • 0037452519 scopus 로고    scopus 로고
    • Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus
    • Shiratori Y, Shiina S, Teratani T, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003;138:299-306
    • (2003) Ann Intern Med , vol.138 , pp. 299-306
    • Shiratori, Y.1    Shiina, S.2    Teratani, T.3
  • 20
    • 0035872948 scopus 로고    scopus 로고
    • Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
    • Kubo S, Nishiguchi S, Hirohashi K, et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001;134:963-7
    • (2001) Ann Intern Med , vol.134 , pp. 963-967
    • Kubo, S.1    Nishiguchi, S.2    Hirohashi, K.3
  • 21
    • 33845651747 scopus 로고    scopus 로고
    • Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers
    • Tateishi R, Shiina S, Yoshida H, et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006;44:1518-27
    • (2006) Hepatology , vol.44 , pp. 1518-1527
    • Tateishi, R.1    Shiina, S.2    Yoshida, H.3
  • 22
    • 0034993211 scopus 로고    scopus 로고
    • Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
    • Leung NW, Lai CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy. Hepatology 2001;33:1527-32
    • (2001) Hepatology , vol.33 , pp. 1527-1532
    • Leung, N.W.1    Lai, C.L.2    Chang, T.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.